entertainment -WSS

entertainment

author：focus 2025-08-08 08:10:15 - browse：6295

Among the pharmaceutical companies’ many objections to the Biden administration’s drug pricing program is a set of provisions the industry says will warp how cancer drugs are developed. On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution.

“What we were asking — and are asking now — is a very simple fix,” said Soriot at the STAT Future Summit, saying that “the impact on health care costs would be very marginal.”

The problem, executives say, is that companies developing cancer drugs today generally start small and then go big. They seek approval first in a small setting, such as patients who have exhausted all other therapies, where it’s easiest in terms of trial size and length to show a benefit. Then they go into larger settings, such as newly diagnosed patients, where studies take longer but the revenue potential is much higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Scientific mystery highlights the blind spots in genomics databases

entertainment

explore

WSS

Burning questions for the 2024 JPM Healthcare Conference

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

JPM: CVS says Medicare Advantage patients are impacting profits

Mass General Brigham physicians react to latest merger step

New weight loss drugs work. But how can they best be used?

AdventHealth escalates lawsuit against insurance vendor Multiplan

explore

entertainment

focus

Apple is now the first public company to be valued at $3 trillion

Four alarming medical procedures we’re glad history forgot

23andMe had bad news about my health. I wish a person had delivered it

Medicare Advantage 2025 payments will dip, Biden administration says

United colonoscopy coverage change 'may cost lives,' doctors say

Insurer loopholes limit power of law against surprise medical bills

Sports medicine is finally prioritizing gender equality

Chronically ill young patients struggle to find fertility info

In Memoriam: Notable people who died in 2023

Ahead of JPM, here's who's profiting most in health care

knowledge

Insurer loopholes limit power of law against surprise medical bills

Bird flu reported in person exposed to presumably infected cattle

Pancreatic cancer is often deadly, but new discoveries are raising hope

Morgan Health, with ambitious aims, wants you to know it’s still here

First Opinion on colorectal cancer screening: letter and response

U.K. decision on ALS drug has neurologists, advocates up in arms

entertainment

focus

explore

hotspot